SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cipher Pharmaceuticals Inc. (CPHRF) 当前追踪市盈率 (P/E) 为 13.1, 前瞻市盈率为 19.6. 追踪盈利收益率为 7.61%, 前瞻盈利收益率 5.10%. PEG 0.10 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (85/100, 通过) — 市盈率低于市场平均水平 (13.1); PEG ≤ 1.0 — Peter Lynch 低估标准 (0.10); 盈利收益率超过债券收益率 (7.61%).
- PEG 比率 0.10 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 追踪盈利收益率 7.61% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 86/100 其中 6/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
85/100
Price-to-Earnings & upside
Proven by this page
✓
健康
83/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CPHRF
估值倍数
P/E (TTM)13.1
前瞻 P/E19.6
PEG 比率0.10
前瞻 PEG1.77
P/B 比率0.00
P/S 比率7.12
EV/EBITDA0.0
每股数据
EPS (TTM)$1.07
前瞻 EPS（预估）$0.72
每股账面价值$0.00
每股营收$1.98
每股自由现金流$0.00
收益率与内在价值
盈利收益率7.61%
Forward Earnings Yield5.10%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-1.45 |
$40.74M |
$-39.15M |
-96.1% |
| 2017 |
$0.16 |
$40.32M |
$4.28M |
10.6% |
| 2018 |
$0.02 |
$22.75M |
$543K |
2.4% |
| 2019 |
$0.12 |
$22.45M |
$3.24M |
14.4% |
| 2020 |
$0.18 |
$21.61M |
$4.55M |
21.1% |
| 2021 |
$0.29 |
$21.94M |
$7.76M |
35.4% |
| 2022 |
$0.99 |
$20.68M |
$26.64M |
128.8% |
| 2023 |
$0.80 |
$21.16M |
$20.38M |
96.3% |
| 2024 |
$0.46 |
$33.36M |
$11.55M |
34.6% |
| 2025 |
$1.07 |
$51.33M |
$27.81M |
54.2% |
